Menzel Garry E 4
4 · Adaptimmune Therapeutics PLC · Filed Jul 1, 2024
Insider Transaction Report
Form 4
Menzel Garry E
Director
Transactions
- Award
Option to purchase Ordinary Shares
2024-07-01+1,121,604→ 1,121,604 totalExercise: $0.16From: 2025-07-01Exp: 2034-07-01→ Ordinary Shares (1,121,604 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.13 based on an exchange rate of $U.S. 1.263714 to GBP1.00. The actual exercise price will be the pounds sterling amount.